IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

NCT05958121 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Cancer
Recurrent Cancer
Solid Tumor, Adult
Cancer

Interventions

BIOLOGICAL: IMA402 (Phase Ia)
BIOLOGICAL: IMA402 (Phase Ib)
BIOLOGICAL: IMA402 (Phase II)

Sponsor

Immatics Biotechnologies GmbH